BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23700715)

  • 1. Pathology of renal cell carcinoma: an update.
    Lopez-Beltran A; Cheng L; Vidal A; Scarpelli M; Kirkali Z; Blanca A; Montironi R
    Anal Quant Cytopathol Histpathol; 2013 Apr; 35(2):61-76. PubMed ID: 23700715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The New WHO Category of "Molecularly Defined Renal Carcinomas": Clinical and Diagnostic Features and Management Implications.
    Kanakaraj J; Chang J; Hampton LJ; Smith SC
    Urol Oncol; 2024 Jul; 42(7):211-219. PubMed ID: 38519377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney cancer: The next decade.
    Turajlic S; Swanton C; Boshoff C
    J Exp Med; 2018 Oct; 215(10):2477-2479. PubMed ID: 30217855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The World Health Organization 2022 Classification of renal tumors: key updates for urologists.
    Caliò A; Amparore D; Roussel E; Bertolo R; Erdem S; Marchioni M; Pavan N; Campi R;
    Minerva Urol Nephrol; 2023 Dec; 75(6):766-769. PubMed ID: 38126288
    [No Abstract]   [Full Text] [Related]  

  • 5. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters.
    Delahunt B; Cheville JC; Martignoni G; Humphrey PA; Magi-Galluzzi C; McKenney J; Egevad L; Algaba F; Moch H; Grignon DJ; Montironi R; Srigley JR;
    Am J Surg Pathol; 2013 Oct; 37(10):1490-504. PubMed ID: 24025520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification.
    Inamura K
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29053609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cell carcinoma: Review of etiology, pathophysiology and risk factors.
    Petejova N; Martinek A
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):183-94. PubMed ID: 26558360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal Cell Carcinoma: Diagnosis and Management.
    Gray RE; Harris GT
    Am Fam Physician; 2019 Feb; 99(3):179-184. PubMed ID: 30702258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary Renal Cell Carcinoma (PRCC): An Update.
    Akhtar M; Al-Bozom IA; Al Hussain T
    Adv Anat Pathol; 2019 Mar; 26(2):124-132. PubMed ID: 30507616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The WHO/ISUP grading system for renal carcinoma].
    Moch H
    Pathologe; 2016 Jul; 37(4):355-60. PubMed ID: 27271258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clear Cell Papillary Renal Cell Carcinoma.
    Zhao J; Eyzaguirre E
    Arch Pathol Lab Med; 2019 Sep; 143(9):1154-1158. PubMed ID: 30672334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies.
    Warren AY; Harrison D
    World J Urol; 2018 Dec; 36(12):1913-1926. PubMed ID: 30123932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma.
    Hsieh JJ; Purdue MP; Signoretti S; Swanton C; Albiges L; Schmidinger M; Heng DY; Larkin J; Ficarra V
    Nat Rev Dis Primers; 2017 Mar; 3():17009. PubMed ID: 28276433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cancer.
    Capitanio U; Montorsi F
    Lancet; 2016 Feb; 387(10021):894-906. PubMed ID: 26318520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma.
    Jonasch E; Gao J; Rathmell WK
    BMJ; 2014 Nov; 349():g4797. PubMed ID: 25385470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdoid collecting duct carcinoma with lymphangitic carcinomatosis causing acute lethal chylopericardium.
    Alvarez Moreno JC; Pagacz M; Mejia O; Oh KS; Medina AM
    Respir Med Case Rep; 2020; 31():101240. PubMed ID: 33072511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Immunoprofiles of Renal Cell Carcinoma Subtypes.
    Kim M; Joo JW; Lee SJ; Cho YA; Park CK; Cho NH
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32150988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of SNHG12 regulates the viability and invasion of renal cell carcinoma cells through modulation of HIF1α.
    Chen Q; Zhou W; Du SQ; Gong DX; Li J; Bi JB; Li ZH; Zhang Z; Li ZL; Liu XK; Kong CZ
    Cancer Cell Int; 2019; 19():128. PubMed ID: 31114448
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.